Sex-specific Trends in 4-year Survival in 37 276 Men and Women with Acute Myocardial Infarction Before the Age of 55 Years in Sweden, 1987-2006: a Register-based Cohort Study
Overview
Affiliations
Objective: To examine sex-specific trends in 4-year mortality among young patients with first acute myocardial infarction (AMI), 1987-2006.
Design: Prospective cohort study.
Setting: Sweden.
Participants: We identified 37 276 cases (19.4% women; age, 25-54 years) from the Swedish Inpatient Register, 1987-2006, who had survived 28 days after an AMI.
Outcome Measures: 4-year mortality from all causes and standard mortality ratio (SMR).
Results: From the first to last 5-year period, the absolute excess risk decreased from 1.38 to 0.50 and 1.53 to 0.59 per 100 person-years among men aged 25-44 and 45-54 years, respectively. Corresponding figures for women were a decrease from 2.26 to 1.17 and from 1.93 to 1.45 per 100 person-years, respectively. Trends for women were non-linear, decreasing to the same extent as those for men until the third period, then increasing. For the last 5-year period, the standardised mortality ratio for young survivors of AMI compared with the general population was 4.34 (95% CI 3.04 to 5.87) and 2.43 (95% CI 2.12 to 2.76) for men aged 25-44 and 45-54 years, respectively, and 13.53 (95% CI 8.36 to 19.93) and 6.42 (95% CI 5.24 to 7.73) for women, respectively. Deaths not associated with cardiovascular causes increased from 21.5% to 44.6% in men and 41.5% to 65.9% in women.
Conclusions: Young male survivors of AMI have low absolute long-term mortality rates, but these rates remain twofold to fourfold that of the general population. After favourable development until 2001, women now have higher absolute mortality than men and a 6-fold to 14-fold risk of death compared with women in the general population.
Kumar D, Bardooli F, Chen W, Huang D, Sankardas M, Ahmed W Egypt Heart J. 2024; 76(1):72.
PMID: 38849606 PMC: 11161447. DOI: 10.1186/s43044-024-00505-2.
Pepio Espuny M, Ortega Vila Y, Aragones Benaiges E, Fernandez Saez J, Millan M, Cabre Vila J Rev Esp Salud Publica. 2023; 97.
PMID: 36655384 PMC: 10558106.
Yildiz I, Rencuzogullari I, Karabag Y, Karakayali M, Artac I, Gurevin M Rev Assoc Med Bras (1992). 2022; 68(6):802-807.
PMID: 35766695 PMC: 9575903. DOI: 10.1590/1806-9282.20220033.
Gili S, Giuliani M, Santagostino Baldi G, Teruzzi G, Pravettoni G, Montorsi P Front Cardiovasc Med. 2022; 9:844563.
PMID: 35345485 PMC: 8957226. DOI: 10.3389/fcvm.2022.844563.
Lee M, Hsu P, Tsai W, Chen Y, Lee H, Lee W Medicine (Baltimore). 2020; 99(19):e19912.
PMID: 32384435 PMC: 7220184. DOI: 10.1097/MD.0000000000019912.